drugset / Trial / NCT01360671

IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

NCT01360671

Phase 2 Withdrawn Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the efficacy of iv sildenafil in term and near term infants with PPHN (persistent pulmonary hypertension of the newborn), by measuring the need for inhaled nitric oxide (iNO) or extracorporeal membrane oxygenation (ECMO) compared to a historical control group not treated with sildenafil.

Timeline

Start
2012-03
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 0.03 mg/kg Intravenous